These patterns may indicate electrolyte imbalances, inadequate caloric intake, underlying thyroid dysfunction, or a need for dose adjustment
Without InBody monitoring, protein optimisation, and resistance training, lean mass loss on GLP-1 therapy is likely and clinically significant
This is an exciting time for the field and the future of psychiatric medicine will likely see more cross-disciplinary treatments like this, where drugs initially developed for metabolic disorders find utility in treating psychiatric conditions
This is ABC News Daily.Elise, the hype over Ozempic, it's really real, isn't it
& Quinn, J
As prices become more affordable, these drugs could transform chronic disease management for millions